Skip to main content
Advertisement

< Back to Article

Table 1.

Clinical Features, Sensory, Motor impairment and Skin Reaction by arm for 345 patients.

More »

Table 1 Expand

Fig 1.

Azathioprine study Flow chart.

More »

Fig 1 Expand

Table 2.

Adverse Reactions encountered in the study (n = 345).

More »

Table 2 Expand

Table 3.

Adverse conditions resulting in withdrawal (n = 59).

More »

Table 3 Expand

Table 4.

Clinical Features and Laboratory investigations of patients who died.

More »

Table 4 Expand

Fig 2.

Comparison of the score (Skin, Sensory & Motor) differences for patients in each treatment arm from Baseline to Endpoint (n = 279) and for each parameter combined, skin, sensory, motor and combined scores.

More »

Fig 2 Expand

Fig 3.

Kaplan Meier Curve showing Time to recurrence in each treatment arm.

More »

Fig 3 Expand

Fig 4.

Comparison of the score (Skin, Sensory & Motor) differences for patients in each treatment arm between Baseline and 48 weeks in study (n = 134) and for each parameter combined, skin, sensory and motor.

More »

Fig 4 Expand

Table 5.

New NFI- All affected nerve compared from baseline to endpoint of study assessing both motor and sensory function (n = 134).

More »

Table 5 Expand

Fig 5.

Score Changes by type of change and for each parameter (combined, skin, sensory and motor) for the whole cohort by the Intention to treat analysis (ITTA) (n = 279).

More »

Fig 5 Expand